Literature DB >> 10817509

Regulatory effect of interleukin-4 and interleukin-13 on colon cancer cell adhesion.

T Kanai1, M Watanabe, A Hayashi, A Nakazawa, T Yajima, A Okazawa, M Yamazaki, H Ishii, T Hibi.   

Abstract

To assess the role of interleukin-4 (IL-4) and interleukin-13 (IL-13) in colon cancer cell-cell adhesion, we investigated the effect of both cytokines in human colon cancer cell line, colo205 cell-cell adhesion. IL-4 receptor was expressed on the cell surface of colo205, and recombinant IL-4 inhibited colo205 cell-cell adhesion in a dose-dependent fashion without inhibiting cell proliferation. Flow cytometric analysis revealed that monoclonal antibodies (mAbs) directed against E-cadherin and carcinoembryonic antigen (CEA) inhibited colo205 cell-cell adhesion and IL-4 significantly inhibited the expression of E-cadherin and CEA. IL-13 also inhibited colo205 cell-cell adhesion. These results indicated that IL-4 and IL-13 inhibited colon cancer cell-cell adhesion by down-regulation of E-cadherin and CEA molecules. We then investigated the expression of both cytokines from freshly isolated colon cancer tumour-infiltrating lymphocytes (TILs). With reverse transcription-polymerase chain reaction and flow cytometric analysis, we demonstrated that colon TILs expressed IL-4 and IL-13 mRNA and protein. These results suggest that Th 2 type cytokines IL-4 and IL-13 locally-produced from TILs may regulate colon cancer adhesion by down-regulation of adhesion molecules.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10817509      PMCID: PMC2374515          DOI: 10.1054/bjoc.2000.1113

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  Prognostic correlations of operable carcinoma of the rectum.

Authors:  C A Carlon; G Fabris; C Arslan-Pagnini; A M Pluchinotta; E Chinelli; S Carniato
Journal:  Dis Colon Rectum       Date:  1985-01       Impact factor: 4.585

2.  Prognosis in colon cancer: a pathologic reassessment.

Authors:  D Murray; A Hreno; J Dutton; L G Hampson
Journal:  Arch Surg       Date:  1975-08

3.  Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule.

Authors:  S Benchimol; A Fuks; S Jothy; N Beauchemin; K Shirota; C P Stanners
Journal:  Cell       Date:  1989-04-21       Impact factor: 41.582

4.  Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor.

Authors:  D S Hoon; M Banez; E Okun; D L Morton; R F Irie
Journal:  Cancer Res       Date:  1991-04-15       Impact factor: 12.701

5.  Tumor-infiltrating lymphocytes from human colon carcinomas. Functional and phenotypic characteristics after long-term culture in recombinant interleukin 2.

Authors:  Y K Yoo; D S Heo; K Hata; D H Van Thiel; T L Whiteside
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

6.  The influence of tumor lymphocytic infiltration on long term survival of surgically treated colorectal cancer patients.

Authors:  A Di Giorgio; C Botti; A Tocchi; P Mingazzini; M Flammia
Journal:  Int Surg       Date:  1992 Oct-Dec

7.  E-cadherin expression during the acidic FGF-induced dispersion of a rat bladder carcinoma cell line.

Authors:  B Boyer; S Dufour; J P Thiery
Journal:  Exp Cell Res       Date:  1992-08       Impact factor: 3.905

8.  Interleukin 4 receptor expression and growth inhibition of gastric carcinoma cells by interleukin 4.

Authors:  T Morisaki; D H Yuzuki; R T Lin; L J Foshag; D L Morton; D S Hoon
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

9.  Specific immune recognition of autologous tumor by lymphocytes infiltrating colon carcinomas: analysis by cytokine secretion.

Authors:  S S Hom; S A Rosenberg; S L Topalian
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

10.  Interleukin 13 inhibits growth of human renal cell carcinoma cells independently of the p140 interleukin 4 receptor chain.

Authors:  N I Obiri; S R Husain; W Debinski; R K Puri
Journal:  Clin Cancer Res       Date:  1996-10       Impact factor: 12.531

View more
  20 in total

1.  Epithelial interleukin-4 receptor expression promotes colon tumor growth.

Authors:  Felicitas L Koller; Daniel G Hwang; E A Dozier; Barbara Fingleton
Journal:  Carcinogenesis       Date:  2010-02-22       Impact factor: 4.944

2.  Expression of interleukin-4 and interleukin-13 and their receptors in colorectal cancer.

Authors:  Andrea Formentini; Philipp Braun; Harald Fricke; Karl-Heinrich Link; Doris Henne-Bruns; Marko Kornmann
Journal:  Int J Colorectal Dis       Date:  2012-03-24       Impact factor: 2.571

3.  Duodenal helminth infection alters barrier function of the colonic epithelium via adaptive immune activation.

Authors:  Chien-wen Su; Yue Cao; Jess Kaplan; Mei Zhang; Wanglin Li; Michelle Conroy; W Allan Walker; Hai Ning Shi
Journal:  Infect Immun       Date:  2011-03-28       Impact factor: 3.441

4.  IL-13 induces the expression of 11βHSD2 in IL-13Rα2 dependent manner and promotes the malignancy of colorectal cancer.

Authors:  Li Jiang; Qi Cheng; Binhao Zhang; Mingzhi Zhang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

5.  Coexpression of carcinoembryonic antigen and E-cadherin in colorectal adenocarcinoma with liver metastasis.

Authors:  Jin C Kim; Seon A Roh; Hee C Kim; Kum H Koo; Young K Cho; Chang S Yu; Young M Kwon; Jung S Kim
Journal:  J Gastrointest Surg       Date:  2003-11       Impact factor: 3.452

6.  Elevated IL-13Ralpha2 in intestinal epithelial cells from ulcerative colitis or colorectal cancer initiates MAPK pathway.

Authors:  Debasmita Mandal; Alan D Levine
Journal:  Inflamm Bowel Dis       Date:  2010-05       Impact factor: 5.325

7.  The lL-8 and IL-13 gene polymorphisms in inflammatory bowel disease and colorectal cancer.

Authors:  Anna Walczak; Karolina Przybylowska; Lukasz Dziki; Andrzej Sygut; Cezary Chojnacki; Jan Chojnacki; Adam Dziki; Ireneusz Majsterek
Journal:  DNA Cell Biol       Date:  2012-06-28       Impact factor: 3.311

8.  Genetic copy number alterations and IL-13 expression differences in papillary thyroid cancers and benign nodules.

Authors:  ZeFei Zhao; Qing Wei; Yongju Zhao; Fukang Sun; Xiaolong Jin; Bin Cui; Guang Ning
Journal:  Endocrine       Date:  2009-06-09       Impact factor: 3.633

9.  A systemic antitumor immune response prevents outgrowth of lung tumors after i.v. rechallenge but is not able to prevent growth of experimental liver tumors.

Authors:  Frederieke H van Duijnhoven; Remco I J M Aalbers; Joost Rothbarth; Onno T Terpstra; Peter J K Kuppen
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

10.  Interleukin-13 exerts autocrine growth-promoting effects on human pancreatic cancer, and its expression correlates with a propensity for lymph node metastases.

Authors:  Andrea Formentini; Olga Prokopchuk; Joern Sträter; Joerg Kleeff; Lukasz Filip Grochola; Gerd Leder; Doris Henne-Bruns; Murray Korc; Marko Kornmann
Journal:  Int J Colorectal Dis       Date:  2008-08-31       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.